These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1093 related items for PubMed ID: 18453021

  • 1. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L, Armstrong J, Buckney S, Assiri M, Cannon M, Holmberg O.
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
    Bayley AJ, Catton CN, Haycocks T, Kelly V, Alasti H, Bristow R, Catton P, Crook J, Gospodarowicz MK, McLean M, Milosevic M, Warde P.
    Radiother Oncol; 2004 Jan; 70(1):37-44. PubMed ID: 15036850
    [Abstract] [Full Text] [Related]

  • 3. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field.
    Milecki P, Piotrowski T, Dymnicka M.
    Neoplasma; 2004 Jan; 51(1):64-9. PubMed ID: 15004663
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P, Laliberte B, Allaw A, Ailleres N, Idri K, Hay MH, Moscardo CL, Gourgou S, Dubois JB, Azria D.
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U, Bogner J, Georg D, Auberger T, Pötter R.
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [Abstract] [Full Text] [Related]

  • 10. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G, Hancock SL, Boyer AL.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):267-84. PubMed ID: 15093924
    [Abstract] [Full Text] [Related]

  • 11. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D, Martinez A, Yan D, Lockman D, Wallace M, Gustafson G, Chen P, Vicini F, Wong J.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):400-8. PubMed ID: 15667959
    [Abstract] [Full Text] [Related]

  • 12. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1297-308. PubMed ID: 16029785
    [Abstract] [Full Text] [Related]

  • 13. Radiotherapy of prostate cancer with multileaf collimators (MLCs) optimization of the undulating dose distribution at the MLC edge.
    Koelbl O, Schwab F, Bratengeier K, Vordermark D, Flentje M.
    Strahlenther Onkol; 2005 Feb 01; 181(2):108-12. PubMed ID: 15702299
    [Abstract] [Full Text] [Related]

  • 14. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A, Töws N, Schmidberger H, Hess CF.
    Strahlenther Onkol; 2005 Dec 01; 181(12):789-95. PubMed ID: 16362789
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of two treatment techniques (six coplanar fields and two dynamic arcs).
    Jereczek-Fossa BA, Cattani F, D'Onofrio A, Cambria R, Kowalczyk A, Corallo A, Vavassori A, Zerini D, Ivaldi GB, DeCobelli O, Orecchia R.
    Radiother Oncol; 2006 Dec 01; 81(3):294-302. PubMed ID: 17113670
    [Abstract] [Full Text] [Related]

  • 19. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model.
    Koelbl O, Richter S, Flentje M.
    Int J Radiat Oncol Biol Phys; 1999 Dec 01; 45(5):1193-8. PubMed ID: 10613312
    [Abstract] [Full Text] [Related]

  • 20. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS, Dong L, McGary JE, Mai WY, Grant W, Butler EB.
    Med Dosim; 2005 Dec 01; 30(1):25-30. PubMed ID: 15749008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.